Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2025-05-04 2025-05-04
Drug Identification Number 02457474 02457474
Brand name ADENOSINE INJECTION ADENOSINE INJECTION
Common or Proper name ADENOSINE INJECTION ADENOSINE INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients ADENOSINE ADENOSINE
Strength(s) 3MG 3MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 2mL 2mL
ATC code C01EB C01EB
ATC description OTHER CARDIAC PREPARATIONS OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2025-05-03 2025-05-03
Actual start date
Estimated end date 2025-05-26 2025-05-26
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that our Adenosine Injection 3 mg/mL prefilled syringe 2 mL may be facing a backorder. During this time, our Adenosine Injection 3 mg/mL SD Vial 2 mL will be available for substitution. Fresenius Kabi Canada regrets to advise that our Adenosine Injection 3 mg/mL prefilled syringe 2 mL may be facing a backorder. During this time, our Adenosine Injection 3 mg/mL SD Vial 2 mL will be available for substitution.
Health Canada comments